[Edaily Reporter Kwon Oh Seok ] CARRY(313760)announced on the 27th that it is withdrawing its plan for a rights offering worth approximately 10 billion won. The company explained, "After comprehensively reviewing our fundraising plans and various conditions, we have decided to withdraw the previous decision to conduct a third-party allocation rights offering." The company had originally decided to conduct the capital increase in August of last year and had planned to proceed with a third-party allocation to the Monarch No. 1 Consortium.
Disclosure Plus
CARRY Withdraws Plan for 10 Billion Won Rights Offering
Kwon Oh Seok
2026-08-27 16:41:46
Economy
Corporation
IT·Science
Economy
Shifting from Short-Term to Medium- and Long-Term... Appeal of Commercial Paper as a Funding Source Plummets
Fluctuations in credit spreads serve as an indicator of investor sentiment and capital flows in the corporate bond market. “Credit Signal” provides an intuitive analysis of the market’s overall trends…
Corporation
Jeong Yong-jin Starts by Replacing E-MART Co., Ltd.’s CEO… Appoints Entire Executive Team in Their 40s
Shinsegae Co.,Ltd Chairman Chung Yong-jin is returning to the forefront of management at E-MART Co., Ltd.(139480). Unlike in 2013, when he stepped down as a registered director and entrusted the busin…
IT·Science
HANALL BIOPHARMA CO.,LTD’s ‘Batoclimab’ Receives First New Drug Approval in China Nine Years After Technology Export
“Batoclimab,” a treatment for autoimmune diseases developed by HANALL BIOPHARMA CO.,LTD(009420), has received new drug approval in China. This comes approximately nine years after the company licensed…
